Login / Signup

Evaluation of Analytical Performance of the STANDARD TM M10 MPX/OPX Assay for the Simultaneous DNA Detection and Clade Attribution of Monkeypox virus .

Alessandro ManconAngelo RaccagniGloria GagliardiDavide MoscheseAlberto RizzoAndrea GiacomelliMiriam CutreraFederica SalariFiorenza BracchittaSpinello AntinoriAndrea GoriGiuliano RizzardiniAntonella CastagnaMaria Rita GismondoSilvia NozzaDavide Mileto
Published in: Emerging microbes & infections (2024)
Monkeypox virus (MPXV) infection confirmation needs reliable polymerase chain reaction (PCR) assays; in addition, viral clade attribution is a key factor in containment measures, considering a more severe syndrome in clade I and possibility of simultaneous circulation. This study aims to evaluate the performance of all-in-one STANDARD M10 MPX/OPX (SD BIOSENSOR, South Korea - M10). Frozen samples from 205 subjects were selected and stratified according to routine test results (RealStar® Orthopoxvirus PCR Kit 1.0, altona DIAGNOTICS, Germany - RS; RS-1): in details, 100 negative skin lesions (SL) and 200 positive samples at variable stage of infection were analyzed. Positive samples were retested with RS (RS-2). Positive and Negative Percent Agreement (PPA, NPA) were calculated. The median (IQR) Ct values of RS and M10 (OPXV target) assays were highly similar. The PPA of M10 compared to RS-1 was 89.5% considering system interpretation, and 96.0%, when the operator classified results as positive if any target was detected; NPA was 100%. Comparing RS-2 run and M10, an overall concordance of 95.3% between assays was found; however, considering operator interpretation, M10 returned more positive results than RS-2. The occurrence of False Negative results was likely associated to influence of thawing on low viral concentration; no False Positive tests were observed. All samples collected at the time of Mpox diagnosis were positive and M10 correctly attributed the clade (West-Africa/II). M10 MPX/OPX assay demonstrated high reliability in confirming MPXV infection and clade attribution.
Keyphrases
  • high throughput
  • sars cov
  • risk assessment
  • magnetic resonance
  • magnetic resonance imaging
  • gold nanoparticles
  • clinical practice
  • circulating tumor
  • single cell